Literature DB >> 10773857

Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population.

S B Patten1, L M Metz, M A Reimer.   

Abstract

The objective of this paper was to evaluate the lifetime and point prevalence of major depression in a population-based Multiple Sclerosis (MS) clinic sample, and to describe associations between selected biopsychosocial variables and the prevalence of lifetime major depression in this sample. Subjects who had participated in an earlier study were re-contacted for additional data collection. Eighty-three per cent (n=136) of those eligible consented to participate. Each subject completed the Composite International Diagnostic Interview (CIDI) and an interviewer-administered questionnaire evaluating a series of biopsychosocial variables. The lifetime prevalence of major depression in this sample was 22.8%, somewhat lower than previous estimates in MS clinic populations. Women, those under 35, and those with a family history of major depression had a higher prevalence. Also, subjects reporting high levels of stress and heavy ingestion of caffeine (>400 mg) had a higher prevalence of major depression. As this was a cross-sectional analysis, the direction of causal effect for the observed associations could not be determined. By identifying variables that are associated with lifetime major depression, these data generate hypotheses for future prospective studies. Such studies will be needed to further understand the etiology of depressive disorders in MS.

Entities:  

Mesh:

Year:  2000        PMID: 10773857     DOI: 10.1177/135245850000600210

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  35 in total

1.  Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.

Authors:  Peter J Jongen; Dirk Lehnick; Evert Sanders; Pierette Seeldrayers; Sten Fredrikson; Magnus Andersson; Joachim Speck
Journal:  Health Qual Life Outcomes       Date:  2010-11-15       Impact factor: 3.186

2.  Depression in multiple sclerosis: a longitudinal analysis.

Authors:  Claudia C Beal; Alexa K Stuifbergen; Adama Brown
Journal:  Arch Psychiatr Nurs       Date:  2007-08       Impact factor: 2.218

3.  Attributional style and depression in multiple sclerosis: the learned helplessness model.

Authors:  Gray A Vargas; Peter A Arnett
Journal:  Int J MS Care       Date:  2013

4.  Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilience.

Authors:  Nunzia Rainone; Alessandro Chiodi; Roberta Lanzillo; Valeria Magri; Anna Napolitano; Vincenzo Brescia Morra; Paolo Valerio; Maria Francesca Freda
Journal:  Qual Life Res       Date:  2016-12-07       Impact factor: 4.147

Review 5.  [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2014-05-20

6.  Unrecognised symptoms of depression in a community-based population with multiple sclerosis.

Authors:  C McGuigan; M Hutchinson
Journal:  J Neurol       Date:  2005-09-27       Impact factor: 4.849

Review 7.  The link between multiple sclerosis and depression.

Authors:  Anthony Feinstein; Sandra Magalhaes; Jean-Francois Richard; Blair Audet; Craig Moore
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

Review 8.  The epidemiology of alcohol consumption and multiple sclerosis: a review.

Authors:  Yu-Jie Wang; Rui Li; Jun-Wei Yan; Ya-Nan Wan; Jin-Hui Tao; Bing Chen; Xiao-Lei Huang; Guo-Jun Yang; Jing Wang; Dong-Qing Ye
Journal:  Neurol Sci       Date:  2014-11-12       Impact factor: 3.307

Review 9.  Co-occurring depression and pain in multiple sclerosis.

Authors:  Kevin N Alschuler; Dawn M Ehde; Mark P Jensen
Journal:  Phys Med Rehabil Clin N Am       Date:  2013-07-23       Impact factor: 1.784

10.  Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression.

Authors:  Mona Moieni; Michael R Irwin; Ivana Jevtic; Richard Olmstead; Elizabeth C Breen; Naomi I Eisenberger
Journal:  Neuropsychopharmacology       Date:  2015-01-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.